1 / 14

Progress of Artemisinin production in East Africa

Progress of Artemisinin production in East Africa. Advanced Bio- Extracts Limited Lisa Amenya. Perspective - who we are. Advanced Bio- Extracts Limited (ABE) Private company with four production subsidiaries operating in the East Africa region African Artemisia Limited (Tanzania)

Download Presentation

Progress of Artemisinin production in East Africa

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Progress of Artemisinin production in East Africa Advanced Bio- Extracts Limited Lisa Amenya

  2. Perspective - who we are... • Advanced Bio- Extracts Limited (ABE) • Private company with four production subsidiaries operating in the East Africa region • African Artemisia Limited (Tanzania) • East African Botanicals Limited (Kenya) • East African Botanicals U Limited (Uganda) • Botanical Extracts EPZ Limited (Kenya)

  3. Objectives • To create a predictable, affordable supply of artemisinin and derivatives – feeding into the ACT chain. • To inject a significant supply of artemisinin to solve industry shortfalls within a 2- year period. • To contribute significantly to bringing the whole chain of ACT production to Africa, in a sustainable way.

  4. Progress on production of artemisinin in East Africa • Can production in East Africa be competitive? Under the right conditions – YES • Raw material • Stable supply being built up rapidly. • Using a range of farming patterns in East Africa. • Processing • Producing and selling small commercial quantities of artemisinin. • Will be supplying more significant commercial quantities of artemisinin by year end 2006. • About to commission a major artemisinin processing and extraction plant in Kenya. • Production of artemisinin based derivatives from the Kenya plant by mid- 2007.

  5. Small scale production

  6. Large scale production

  7. Satellite extraction plant, Uganda

  8. Crude artemisinin

  9. Pure artemisinin

  10. What we are offering… • Supply of artemisinin and derivatives at predictable volumes and prices. • To work with other extractors to purify and derivative their products. • Long- term relationships with growers.

  11. Challenges • Market certainty – clarification of synthetics. • Much more complicated than it appears. • Economy of scale required. • To overcome technical challenges for cost effectiveness • Too much fragmentation will not enhance viability. • Focus on comparative advantages of the region. • Financial support for technical development and investment.

More Related